Recursion Pharmaceuticals Financial Overview
Recursion Pharmaceuticals's market cap is currently $2.22B. The company's EPS TTM is $-0.36; its P/E ratio is -2.35; Recursion Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
